TrianglePUBLICATIONS · 23480528
The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosis.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Br J Haematol
- Publication date
- 2013 May
- First author
- Verstovsek S
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Verstovsek S
- type
- Author
- name
- Mesa RA
- type
- Author
- name
- Gotlib J
- type
- Author
- name
- Levy RS
- type
- Author
- name
- Gupta V
- type
- Author
- name
- DiPersio JF
- type
- Author
- name
- Catalano JV
- type
- Author
- name
- Deininger M
- type
- Author
- name
- Miller C
- type
- Author
- name
- Silver RT
- type
- Author
- name
- Talpaz M
- type
- Author
- name
- Winton EF
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Verstovsek S
- type
- Author
- name
- Mesa RA
- type
- Author
- name
- Gotlib J
- type
- Author
- name
- Levy RS
- type
- Author
- name
- Gupta V
- type
- Author
- name
- DiPersio JF
- type
- Author
- name
- Catalano JV
- type
- Author
- name
- Deininger M
- type
- Author
- name
- Miller C
- type
- Author
- name
- Silver RT
- type
- Author
- name
- Talpaz M
- type
- Author
- name
- Winton EF
- type
- Author
- bibliography ids
- nci-bib-694ed05ef1f623aea7571061
- book metadata
- content sha256
- f26ee434011c8c6d901725b752b3aaadd3d76782786dd9389d8558ae040eafcf
- document type
- citation
- dois
- 10.1111/bjh.12274
- electronic publication date
- display
- 2013 Mar 11
- precision
- day
- year
- 2013
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:23480528
- immutable id
- pubmed:23480528@f26ee434011c8c6d901725b752b3aaadd3d76782786dd9389d8558ae040eafcf
- journal
- abbreviation
- Br J Haematol
- issn electronic
- 1365-2141
- issn print
- 0007-1048
- issue
- 4
- name
- British journal of haematology
- nlm unique id
- 0372544
- pages
- 508-16
- volume
- 161
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 23480528
- provenance
- batch id
- 99e008dabc339d38fd44
- provider
- NCBI PubMed ESummary
- record sha256
- c255e5b12a3ce4aedbdd7c57dab853bfe509b624babe5a37ccb1b5b343ebf12c
- response sha256
- 804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
- retrieved at
- 2026-09-09T23:46:55.094762+00:00
- publication date
- display
- 2013 May
- precision
- month
- year
- 2013
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosis.
Preserved source evidence · Not medical advice